Search results for: “vaccine”
-
Moderna and Lonza announce strategic collaboration to manufacture vaccine against Novel Coronavirus
•
BASEL, SWITZERLAND: Moderna Inc., a clinical stage biotechnology company, and Lonza Ltd. have announced a 10-year strategic collaboration…
-
Scancell initiates development of novel DNA vaccine against COVID-19
•
LONDON: Scancell Holdings plc, the developer of novel immunotherapies for the treatment of cancer, has initiated a research…
-
Scancell Holdings appoints Dr. Phil L’Huillier as new CEO
•
LONDON: Scancell Holdings plc (AIM: SCLP), a developer of cancer immunotherapies, has appointed Dr. Phil L’Huillier as the…
-
Oxford Biomedica reports 36% decline in revenues for 2023
•
LONDON: Oxford Biomedica plc, a leading cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has released…
-
ECO Animal Health Group streamlines operations with Sale of ECOmectin® Horsepaste
•
LONDON, UK: ECO Animal Health Group plc (AIM: EAH), known for its expansive portfolio of veterinary products and…
-
Aptamer Group posts loss in the first half FY24
•
LONDON, UK: Aptamer Group plc (AIM: APTA) has released its unaudited interim financial results for the six months…
-
How to fund your women-owned business in 2024
•
Funding is one of the most important and challenging aspects of running a business, especially for women entrepreneurs.…
-
Saama and Pfizer expand AI partnership to accelerate clinical trials
•
Saama, a leading provider of AI-based solutions for clinical development and commercialization, announced a new multi-year agreement with…
-
AstraZeneca reports strong growth in 2023 despite COVID-19 challenges
•
AstraZeneca, a global biopharmaceutical company, announced its financial results for the full year 2023, showing a 6% increase…
-
Valneva SE has sold Priority Review Voucher for €95 million
•
PARIS, FRANCE: Valneva SE, a company that specializes in vaccines, has sold a PRV (Priority Review Voucher) received…
-
Sanofi reports strong sales and earnings growth in 2023, driven by new products and pipeline
•
PARIS, FRANCE: Sanofi, a global leader in healthcare, announced today its financial results for the year 2023, showing…
-
AstraZeneca signs deal to acquire Icosavax Inc. for $1.1 billion
•
LONDON, UK: AstraZeneca has entered into a definitive agreement to acquire Icosavax Inc. (NASDAQ: ICVX), a US-based clinical-stage…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.